Literature DB >> 29806487

Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications.

Francesca Romana Ponziani1, Maria Assunta Zocco1, Lucia Cerrito1, Antonio Gasbarrini1, Maurizio Pompili1.   

Abstract

INTRODUCTION: The gut liver axis is an operative unit that works to protect the human body against potentially harmful substances and microorganisms, maintaining the homeostasis of the immune system. Liver cirrhosis profoundly alters this complex system. The intestine becomes more permeable allowing the translocation of bacteria, bacterial products and fragments into the portal circulation, triggering an abnormal local and systemic inflammatory response and a condition of perpetual immunologic alarm. This immune-inflammatory disorder related to dysbiosis is involved in the development of liver damage and liver cirrhosis complications and increases intestinal permeability in a vicious circle. Areas covered: The most relevant studies on bacterial translocation, the mechanism of intestinal barrier dysfunction and its consequences in patients with liver cirrhosis have been revised through a PubMed search. Data have been discussed with particular regard to their significance in clinical practice. Expert commentary: The assessment of bacterial translocation and intestinal permeability is not currently used in clinical practice but may be useful to stratify patients' prognosis.

Entities:  

Keywords:  Liver cirrhosis; ascites; bacterial translocation; dysbiosis; gut microbiota; hepatic encephalopathy; immune-inflammatory disorder; inflammation; intestinal permeability; portal hypertension

Mesh:

Substances:

Year:  2018        PMID: 29806487     DOI: 10.1080/17474124.2018.1481747

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  32 in total

1.  Compromise of α-Defensin Function in Liver Cirrhosis Facilitates the Toxic Relationship Between Gut Permeability and Endotoxemia.

Authors:  Kanakaraju Kaliannan
Journal:  Dig Dis Sci       Date:  2018-10       Impact factor: 3.199

Review 2.  Leaky gut: mechanisms, measurement and clinical implications in humans.

Authors:  Michael Camilleri
Journal:  Gut       Date:  2019-05-10       Impact factor: 23.059

Review 3.  Gut Barrier and Microbiota in Cirrhosis.

Authors:  Cyriac A Philips; Philip Augustine
Journal:  J Clin Exp Hepatol       Date:  2021-09-03

Review 4.  Management of hepatorenal syndrome in liver cirrhosis: a recent update.

Authors:  Chinmay Bera; Florence Wong
Journal:  Therap Adv Gastroenterol       Date:  2022-06-14       Impact factor: 4.802

5.  Persistent Hyperactivation of Endothelial Cells in Patients with Alcoholic Hepatitis.

Authors:  Ying Xia; Jing Yang; Arun J Sanyal; Vijay H Shah; Naga P Chalasani; Qigui Yu; Xiaoqun Zheng; Wei Li
Journal:  Alcohol Clin Exp Res       Date:  2020-04-21       Impact factor: 3.455

Review 6.  Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?

Authors:  Cezmi A Akdis
Journal:  Nat Rev Immunol       Date:  2021-04-12       Impact factor: 53.106

7.  Blood Biomarkers of Intestinal Epithelium Damage Regenerating Islet-derived Protein 3α and Trefoil Factor 3 Are Persistently Elevated in Patients with Alcoholic Hepatitis.

Authors:  Jing Yang; Fahim Syed; Ying Xia; Arun J Sanyal; Vijay H Shah; Naga Chalasani; Xiaoqun Zheng; Qigui Yu; Yongliang Lou; Wei Li
Journal:  Alcohol Clin Exp Res       Date:  2021-03-11       Impact factor: 3.455

Review 8.  Intestinal Barrier and Permeability in Health, Obesity and NAFLD.

Authors:  Piero Portincasa; Leonilde Bonfrate; Mohamad Khalil; Maria De Angelis; Francesco Maria Calabrese; Mauro D'Amato; David Q-H Wang; Agostino Di Ciaula
Journal:  Biomedicines       Date:  2021-12-31

Review 9.  The pathogenic oral-gut-liver axis: new understandings and clinical implications.

Authors:  Jin Imai; Sho Kitamoto; Nobuhiko Kamada
Journal:  Expert Rev Clin Immunol       Date:  2021-06-08       Impact factor: 5.124

10.  Correlation Between Proton Pump Inhibitors and the Complications of Liver Cirrhosis: A Systematic Review and Meta-Analysis.

Authors:  Seong Jun Hwang; Dong Hyeon Lee; Seong-Joon Koh; Ji Won Kim; Hyun Sun Park; Byeong Gwan Kim; Kook Lae Lee
Journal:  Turk J Gastroenterol       Date:  2022-01       Impact factor: 1.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.